Published in In Vitro Cell Dev Biol Anim on October 28, 1997
Species, interindividual, and tissue specificity in endocrine signaling. Environ Health Perspect (1999) 0.75
New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology (1999) 11.94
Collaborative management to achieve treatment guidelines. Impact on depression in primary care. JAMA (1995) 11.90
Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res (1990) 9.85
The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum (1991) 9.82
Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N Engl J Med (1996) 7.09
Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet (1991) 6.61
The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene (2000) 4.90
Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med (1996) 4.87
Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. Arch Gen Psychiatry (1999) 4.57
Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer (1993) 3.86
An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium. Am J Hum Genet (1995) 3.81
Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res (1996) 3.60
Adult health status of women with histories of childhood abuse and neglect. Am J Med (1999) 3.43
Conversion of diploidy to haploidy. Nature (2000) 3.28
Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst (1999) 3.26
Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res (1994) 3.25
Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat (1982) 2.98
Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer (1998) 2.91
Hereditary factors in cancer. Study of two large midwestern kindreds. Arch Intern Med (1966) 2.86
Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma. Cancer (2001) 2.82
Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst (1992) 2.82
Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia. Blood (2001) 2.73
Chronic neurological sequelae to organophosphate pesticide poisoning. Am J Public Health (1994) 2.70
Comparative study of human and rat mammary tumorigenesis. Lab Invest (1990) 2.58
A randomized trial of nortriptyline for severe chronic tinnitus. Effects on depression, disability, and tinnitus symptoms. Arch Intern Med (1993) 2.41
hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res (1994) 2.39
Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Prev Med (2000) 2.39
Pluripotent neural crest stem cells in the adult hair follicle. Dev Dyn (2004) 2.39
Familial gastric cancer: overview and guidelines for management. J Med Genet (1999) 2.38
Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2. Lancet (1999) 2.36
Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer (1996) 2.33
Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes. J Natl Cancer Inst (1998) 2.33
Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland. Breast Cancer Res Treat (1999) 2.30
Chronic fatigue syndrome criteria. A critique of the requirement for multiple physical complaints. Arch Intern Med (1992) 2.27
Genetic epidemiology of breast cancer and associated cancers in high-risk families. I. Segregation analysis. J Natl Cancer Inst (1983) 2.21
The association between chronic pelvic pain, psychiatric diagnoses, and childhood sexual abuse. Obstet Gynecol (1988) 2.20
Genetic instability of microsatellites in endometrial carcinoma. Cancer Res (1993) 2.20
Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell (1993) 2.17
Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies. J Natl Cancer Inst (1996) 2.17
Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes? Am J Hum Genet (1997) 2.15
Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat. Am J Hum Genet (1999) 2.14
Distressed high utilizers of medical care. DSM-III-R diagnoses and treatment needs. Gen Hosp Psychiatry (1990) 2.13
The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations. J Med Genet (2004) 2.10
A randomized effectiveness trial of collaborative care for patients with panic disorder in primary care. Arch Gen Psychiatry (2001) 2.08
Frustrating patients: physician and patient perspectives among distressed high users of medical services. J Gen Intern Med (1991) 2.08
Somatization: a spectrum of severity. Am J Psychiatry (1991) 2.03
MLH3: a DNA mismatch repair gene associated with mammalian microsatellite instability. Nat Genet (2000) 2.00
A randomized trial of psychiatric consultation with distressed high utilizers. Gen Hosp Psychiatry (1992) 2.00
Role of hormones in mammary cancer initiation and progression. J Mammary Gland Biol Neoplasia (1998) 1.97
BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations. J Cell Biol (2001) 1.96
A polymorphic stop codon in BRCA2. Nat Genet (1996) 1.95
Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect (1996) 1.94
Familial atypical multiple mole-melanoma syndrome. J Med Genet (1978) 1.88
Panic disorder in the primary care setting: comorbidity, disability, service utilization, and treatment. J Clin Psychiatry (1999) 1.88
Transformation of human breast epithelial cells by c-Ha-ras oncogene. Mol Carcinog (1991) 1.87
The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer. Gynecol Oncol (2001) 1.84
Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history. Cancer Res (2001) 1.81
Cancer family "G" revisited: 1895-1970. Cancer (1971) 1.81
Rectal cancer in FAP patient after sulindac. Lancet (1994) 1.80
Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus. Nat Genet (1996) 1.79
Biological and molecular bases of mammary carcinogenesis. Lab Invest (1987) 1.79
A BRCA1 nonsense mutation causes exon skipping. Am J Hum Genet (1998) 1.77
Ehlers-Danlos syndrome and "congenital" arteriovenous fistulae. A clinicopathologic study of a family. JAMA (1965) 1.77
Psychiatric and otologic diagnoses in patients complaining of dizziness. Arch Intern Med (1993) 1.75
Burden: a review of measures used among caregivers of individuals with dementia. Gerontologist (1991) 1.72
Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylbenz[a]anthracene. J Natl Cancer Inst (1978) 1.71
Toward a physiological approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev (1994) 1.68
Cloning and gene mapping of the chromosome 13q14 region deleted in chronic lymphocytic leukemia. Genomics (1997) 1.68
A breast-ovarian cancer susceptibility gene maps to chromosome 17q21. Am J Hum Genet (1993) 1.66
Relationship of chronic pelvic pain to psychiatric diagnoses and childhood sexual abuse. Am J Psychiatry (1988) 1.65
Genetic testing in families with hereditary nonpolyposis colon cancer. JAMA (1999) 1.61
DNA labeling index and structure of the rat mammary gland as determinants of its susceptibility to carcinogenesis. J Natl Cancer Inst (1978) 1.60
A follow-up study of colonic epithelial proliferation as a biomarker ina Native-American family with hereditary nonpolyposis colon cancer. J Natl Cancer Inst (1991) 1.57
IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. Immunity (2001) 1.56
Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences. Am J Pathol (1998) 1.55
What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing. J Clin Oncol (1998) 1.55
Influence of differentiation and cell kinetics on the susceptibility of the rat mammary gland to carcinogenesis. Cancer Res (1980) 1.55
Influence of age and parity on the development of the human breast. Breast Cancer Res Treat (1992) 1.54
Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence. Am J Pathol (1980) 1.54
Epidemiology of pancreatic cancer: an overview. Cancer Detect Prev (2003) 1.54
Medical school pressures and their relationship to anxiety. J Nerv Ment Dis (1984) 1.53
Natural history of hereditary cancer of the breast and colon. Cancer (1982) 1.53
Developmental, cellular, and molecular basis of human breast cancer. J Natl Cancer Inst Monogr (2000) 1.53
Ultrastructural and immunocytochemical characterization of an immortalized human breast epithelial cell line, MCF-10. Cancer Res (1990) 1.53
Validity and responsiveness of the Minimum Data Set. J Am Geriatr Soc (1999) 1.53
An Alu-mediated 6-kb duplication in the BRCA1 gene: a new founder mutation? Am J Hum Genet (1999) 1.52
Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). II. Biomarker studies. Cancer (1985) 1.51
Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Br J Cancer (2011) 1.51
Mammary gland architecture as a determining factor in the susceptibility of the human breast to cancer. Breast J (2002) 1.51
Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer. J Gastrointest Surg (1999) 1.51
Chronic neurologic sequelae to cholinesterase inhibition among agricultural pesticide applicators. Arch Environ Health (1996) 1.51
Heredity and malignant melanoma: implications for early cancer detection. Can Med Assoc J (1968) 1.50
Subsyndromal ("mixed") anxiety--depression in primary care. J Gen Intern Med (1994) 1.50